Vox reporter Sarah Kliff spent over a year reading thousands of ER bills and investigating the reasons behind the costs, including hidden fees, overpriced supplies and out-of-network doctors.
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies’ reputations. Litigation has forced the release of internal documents that are shifting the narrative.
NPR’s Mary Louise Kelly talks with Dr. Carl Eriksson, assistant professor of pediatrics at Oregon Health & Science University School of Medicine, about treating a case of tetanus in a 6-year-old boy.
It’s Match Week, when med students apply for residencies. An economist argues this residency system is a key reason why U.S. doctors are paid around twice much as doctors in other rich nations.
Although federal law prohibits health insurance plans from discriminating against transgender individuals, a Georgia county specifically excludes trans-related health care from coverage.
A little-noticed Trump administration proposal would require hospitals, doctors and insurers to post the true, negotiated price for a medical procedure or service, as opposed to the “list” price.
The Indianapolis-based drugmaker said Monday that it would offer a generic version of Humalog insulin, one of its best-selling medicines. The move could help blunt criticism about high prices.
It was Oregon’s first pediatric case in more than 30 years. “It was difficult to take care of him, to watch him suffer,” says Judith Guzman-Cottrill, an infectious-disease specialist.
While there’s been progress in lowering the death rate from prescription opioids in Oklahoma, the number of opioid prescriptions written in the state outpaces the national average.